目次

Table of Contents

1. Executive Summary

2. Immuno-Oncology Drugs Market Characteristics

3. Immuno-Oncology Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Immuno-Oncology Drugs

5. Immuno-Oncology Drugs Market Size And Growth
5.1. Global Immuno-Oncology Drugs Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Immuno-Oncology Drugs Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Immuno-Oncology Drugs Market Segmentation
6.1. Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
6.2. Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Melanoma
Lung Cancer
Blood Cancer
Renal Cell Carcinoma
Prostate Cancer
Bladder Cancer
Others
6.3. Global Immuno-Oncology Drugs Market, Segmentation By End-user, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Hospitals
Clinics
Ambulatory Surgical Centers
Cancer Research Institutes

7. Immuno-Oncology Drugs Market Regional And Country Analysis
7.1. Global Immuno-Oncology Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Immuno-Oncology Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Immuno-Oncology Drugs Market
8.1. Asia-Pacific Immuno-Oncology Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Immuno-Oncology Drugs Market
9.1. China Immuno-Oncology Drugs Market Overview
9.2. China Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Immuno-Oncology Drugs Market
10.1. India Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Immuno-Oncology Drugs Market
11.1. Japan Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Immuno-Oncology Drugs Market
12.1. Australia Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Immuno-Oncology Drugs Market
13.1. Indonesia Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Immuno-Oncology Drugs Market
14.1. South Korea Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Immuno-Oncology Drugs Market
15.1. Western Europe Immuno-Oncology Drugs Market Overview
15.2. Western Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Immuno-Oncology Drugs Market
16.1. UK Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Immuno-Oncology Drugs Market
17.1. Germany Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Immuno-Oncology Drugs Market
18.4. France Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Immuno-Oncology Drugs Market
19.1. Eastern Europe Immuno-Oncology Drugs Market Overview
19.2. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Immuno-Oncology Drugs Market
20.1. Russia Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Immuno-Oncology Drugs Market
21.1. North America Immuno-Oncology Drugs Market Overview
21.2. North America Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Immuno-Oncology Drugs Market
22.1. USA Immuno-Oncology Drugs Market Overview
22.2. USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Immuno-Oncology Drugs Market
23.1. South America Immuno-Oncology Drugs Market Overview
23.2. South America Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Immuno-Oncology Drugs Market
24.1. Brazil Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Immuno-Oncology Drugs Market
25.1. Middle East Immuno-Oncology Drugs Market Overview
25.2. Middle East Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Immuno-Oncology Drugs Market
26.1. Africa Immuno-Oncology Drugs Market Overview
26.2. Africa Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Immuno-Oncology Drugs Market Competitive Landscape And Company Profiles
27.1. Immuno-Oncology Drugs Market Competitive Landscape
27.2. Immuno-Oncology Drugs Market Company Profiles
27.2.1. Amgen, Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. AstraZeneca Plc
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Bristol-Myers Squibb
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Celgene Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Eli Lilly and Company
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Immuno-Oncology Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Immuno-Oncology Drugs Market

30. Immuno-Oncology Drugs Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global Immuno-Oncology Drugs Market, Segmentation By End-user, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 6: Global Immuno-Oncology Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global Immuno-Oncology Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Asia-Pacific, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: Asia-Pacific, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: China, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: China, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: India, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 13: India, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 14: Japan, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 15: Japan, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 16: Australia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 17: Australia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 18: Indonesia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 19: Indonesia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 20: South Korea, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 21: South Korea, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 22: Western Europe, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 23: Western Europe, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 24: UK, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 25: UK, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 26: Germany, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 27: Germany, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 28: France, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 29: France, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 30: Eastern Europe, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 31: Eastern Europe, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 32: Russia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 33: Russia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 34: North America, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 35: North America, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 36: USA, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 37: USA, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 38: South America, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 39: South America, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 40: Brazil, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 41: Brazil, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 42: Middle East, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 43: Middle East, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 44: Africa, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 45: Africa, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 46: Amgen, Inc. Financial Performance
Table 47: AstraZeneca Plc Financial Performance
Table 48: Bristol-Myers Squibb Financial Performance
Table 49: Celgene Corporation Financial Performance
Table 50: Eli Lilly and Company Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Figure 3: Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 4: Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 5: Global Immuno-Oncology Drugs Market, Segmentation By End-user, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 6: Global Immuno-Oncology Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global Immuno-Oncology Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Asia-Pacific, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: Asia-Pacific, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: China, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: China, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: India, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 13: India, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 14: Japan, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 15: Japan, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 16: Australia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 17: Australia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 18: Indonesia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 19: Indonesia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 20: South Korea, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 21: South Korea, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 22: Western Europe, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 23: Western Europe, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 24: UK, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 25: UK, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 26: Germany, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 27: Germany, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 28: France, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 29: France, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 30: Eastern Europe, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 31: Eastern Europe, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 32: Russia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 33: Russia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 34: North America, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 35: North America, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 36: USA, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 37: USA, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 38: South America, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 39: South America, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 40: Brazil, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 41: Brazil, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 42: Middle East, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 43: Middle East, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 44: Africa, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 45: Africa, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 46: Amgen, Inc. Financial Performance
Figure 47: AstraZeneca Plc Financial Performance
Figure 48: Bristol-Myers Squibb Financial Performance
Figure 49: Celgene Corporation Financial Performance
Figure 50: Eli Lilly and Company Financial Performance